Related Experiment Video
Updated: Aug 5, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Analgosedation in Neonatal Intensive Care: Current Strategies, Challenges, and Future Perspectives
Leonardo Detto1, Eleonora Alfieri1, Anna Munerati1
1Pediatric Clinic, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy.
Insights
Managing pain and stress in neonatal intensive care is complex. Effective analgosedation (pain and sedation management) requires balancing medications with non-pharmacological methods for optimal infant comfort and development.
Area of Science:
- Neonatal Intensive Care Medicine
- Pediatric Pharmacology
- Pain Management
Background:
- Neonatal intensive care units (NICUs) frequently encounter pain and stress in critically ill newborns due to invasive procedures and life support.
- Effective analgosedation is crucial for reducing infant distress, stabilizing physiology, and potentially preventing adverse neurodevelopmental outcomes.
- Neonatal analgosedation is challenging due to infant immaturity, variable drug responses, and the risk of treatment complications.
Purpose of the Study:
- To review current evidence on analgosedation strategies in the NICU.
- To discuss clinical indications, pharmacological and non-pharmacological agents, monitoring, adverse effects, and future directions.
- To emphasize the need for individualized, multimodal approaches to neonatal pain management.
Main Methods:
- This is a narrative review of existing literature on neonatal analgosedation.
- Evidence was synthesized focusing on key aspects of pain and sedation management in NICU settings.
- The review examined pharmacological agents, non-pharmacological interventions, and assessment tools.
Main Results:
- Opioids, benzodiazepines, dexmedetomidine, and ketamine offer benefits but have limitations, necessitating tailored use and monitoring.
- Non-pharmacological methods like sucrose, non-nutritive sucking, and skin-to-skin care should complement pharmacological treatments.
- Validated assessment tools (e.g., COMFORTneo, N-PASS, PIPP-R) aid in standardized pain evaluation and treatment guidance.
Conclusions:
- Optimizing neonatal comfort requires a multidisciplinary, protocol-driven, and family-centered approach.
- Individualized selection and titration of analgosedation agents, alongside non-pharmacological strategies, are essential.
- Future advancements may involve objective monitoring, AI, and precision medicine to refine neonatal pain and stress management.
Abstract:
Pain and stress are frequent and clinically relevant challenges in neonatal intensive care, particularly among preterm and critically ill newborns exposed to repeated invasive procedures, mechanical ventilation, surgery, and advanced life-support interventions. Effective analgosedation is essential to reduce discomfort, attenuate physiological instability, improve tolerance of intensive care procedures, and potentially limit adverse neurodevelopmental consequences. However, neonatal pain and analgosedation management remain complex because of developmental immaturity, pharmacokinetic and pharmacodynamic variability, and the need to balance adequate analgosedation against treatment-related complications. This narrative review summarizes current evidence on analgosedation in the Neonatal Intensive Care Unit, focusing on clinical indications, pharmacological agents, non-pharmacological strategies, monitoring tools, adverse effects, and future perspectives. Opioids, benzodiazepines, dexmedetomidine, and ketamine each have specific potential benefits and limitations, requiring individualized selection, careful titration, and continuous reassessment. Non-pharmacological interventions, including oral sucrose, non-nutritive sucking, facilitated tucking, breastfeeding, skin-to-skin care, and environmental modulation, should be integrated into multimodal pain-management protocols. Validated instruments such as COMFORTneo, N-PASS, and PIPP-R support standardized assessment and guide therapeutic decisions. Future advances may derive from objective monitoring technologies, artificial intelligence, developmental pharmacology, and precision-medicine approaches. A multidisciplinary, protocol-driven, and family-centered strategy is essential to optimize neonatal comfort while minimizing avoidable drug exposure.
Related Concept Videos
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Stages of General Anesthesia
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Skeletal Muscle Relaxants: Therapeutic Uses
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...